Biomerica Inc BMRA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BMRA is a good fit for your portfolio.
News
-
Biomerica provides update on inFoods® IBS expansion
-
Biomerica Reports Third Quarter 2024 Financial Results
-
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
-
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
-
Biomerica Shares Rise After FDA 510(k) Clearance for H Pylori Bacteria Test
Trading Information
- Previous Close Price
- $0.71
- Day Range
- $0.66–0.73
- 52-Week Range
- $0.66–2.13
- Bid/Ask
- $0.68 / $0.69
- Market Cap
- $11.45 Mil
- Volume/Avg
- 88,165 / 71,334
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.21
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 62
- Website
- https://www.biomerica.com
Valuation
|
Metric
|
BMRA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.54 |
Price/Sales | 2.21 |
Price/Cash Flow | — |
Price/Earnings
BMRA
Financial Strength
|
Metric
|
BMRA
|
|---|---|
Quick Ratio | 4.50 |
Current Ratio | 5.63 |
Interest Coverage | — |
Quick Ratio
BMRA
Profitability
|
Metric
|
BMRA
|
|---|---|
Return on Assets (Normalized) | −46.91% |
Return on Equity (Normalized) | −59.92% |
Return on Invested Capital (Normalized) | −55.98% |
Return on Assets
BMRA
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Nygqwfvfr | Qcxfqf | $185.5 Bil | |
SYK
| Stryker Corp | Kjtcfhgy | Chqcv | $128.2 Bil | |
MDT
| Medtronic PLC | Hdnxmjf | Fqlzyw | $106.7 Bil | |
BSX
| Boston Scientific Corp | Jmrsqqvz | Snpnypp | $99.0 Bil | |
DXCM
| DexCom Inc | Zrlmpqytz | Bxcb | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Dfqrwnjhd | Vxwyvq | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ppsnhykl | Vgwt | $24.9 Bil | |
ALGN
| Align Technology Inc | Xypwwzg | Wykxq | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Xslqpzbs | Nfjjl | $18.9 Bil | |
PODD
| Insulet Corp | Fjzyzgqh | Rjwwrk | $11.7 Bil |